Work

Supplementary Figures from Therapeutic Inhibition of the Receptor Tyrosine Kinase AXL Improves Sensitivity to Platinum and Taxane in Ovarian Cancer

Year: 2023

Type: supplementary-materials

Abstract: Supplementary Figures. S1 - AXL and overall survival. High AXL is associated with poor OS. S2 - BGB324 treatment and downstream inhibition. BGB324 treatment inhibits pAXL and downstream activation.

DOI: 10.1158/1535-7163.22510660.v1

Authors: Jeanne M. Quinn, Molly M. Greenwade, Marguerite L. Palisoul, Gregory Opara, Katina Massad, Lei Guo, Peinan Zhao, Hollie Beck-Noia, Ian S. Hagemann, Andrea R. Hagemann, Carolyn K. McCourt, Premal H. Thaker, Matthew A. Powell, David G. Mutch, Katherine C. Fuh

Language: English

Topic: Ovarian cancer diagnosis and treatment

Subfield: Reproductive Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

OpenAlex ID: W4362535640

Cites:

Cited by:

Related to: 10